Tumour markers in the cerebrospinal fluid of patients with central nervous system metastases from extracranial malignancies
- 15 July 1988
- journal article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 175 (2) , 157-166
- https://doi.org/10.1016/0009-8981(88)90005-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Detection of central nervous system metastasis with cerebrospinal fluid beta-2-microglobulinCancer, 2006
- Cerebrospinal fluid beta2-microglobulin: a study in controls and patients with metastatic and non-metastatic neurological diseasesEuropean Journal of Cancer and Clinical Oncology, 1986
- Cerebrospinal Fluid Carcinoembryonic Antigen in Patients With Metastatic and Nonmetastatic Neurological DiseasesArchives of Neurology, 1986
- Cerebrospinal fluid β-glucuronidase activities in patients with central nervous system metastasesClinica Chimica Acta; International Journal of Clinical Chemistry, 1985
- Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patientsCancer, 1982
- Cerebrospinal fluid biochemical markers of central nervous system metastasesAnnals of Neurology, 1980
- CSF -Glucuronidase Assay in the Diagnosis of Neoplastic MeningitisArchives of Neurology, 1980
- Diagnosis of Leukemia or Lymphoma in the Central Nervous System by Beta2-Microglobulin DeterminationNew England Journal of Medicine, 1980
- Malignant cells in cerebrospinal fluid (CSF)Neurology, 1979
- Cerebral Metastases and Carcinoembryonic Antigen in CSFNew England Journal of Medicine, 1975